Bayesian Capital Management’s UiPath PATH Stock Holding History

Bayesian Capital Management’s Portfolio PATH Stock Details PATH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Buy	+36,900	New	+$394K	0.26%	112
2025 Q3	–	Sell	-144,500	Closed	-$1.85M	–	736
2025 Q2	$1.85M	Buy	144,500 +79,000	+121%	+$948K	0.29%	99
2025 Q1	$675K	Buy	65,500 +52,100	+389%	+$670K	0.11%	244
2024 Q4	$170K	Sell	13,400 -88,300	-87%	-$1.17M	0.02%	582
2024 Q3	$1.3M	Buy	+101,700	New	+$1.25M	0.15%	199
2024 Q1	–	Sell	-135,300	Closed	-$3.36M	–	1030
2023 Q4	$3.36M	Buy	135,300 +112,000	+481%	+$2.19M	0.36%	65
2023 Q3	$399K	Buy	+23,300	New	+$388K	0.05%	414
2023 Q2	–	Sell	-176,800	Closed	-$3.1M	–	994
2023 Q1	$3.1M	Sell	176,800 -25,900	-13%	-$391K	0.38%	62
2022 Q4	$2.58M	Buy	+202,700	New	+$2.5M	0.38%	41
2022 Q1	–	Sell	-15,900	Closed	-$686K	–	883
2021 Q4	$686K	Buy	+15,900	New	+$784K	0.22%	138

Other funds holding PATH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bayesian Capital Management's PATH Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in UiPath (PATH) in Q2 2026: 36,900 shares worth $401K. The stake represents 0.26% of the portfolio and ranks #112 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in PATH as recently as Q2 2025.

Bayesian Capital Management first reported a position in PATH in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.36M in Q4 2023. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

Bayesian Capital Management held 36,900 shares of UiPath worth $401K as of Q2 2026.
UiPath was a new Bayesian Capital Management position in Q2 2026.
UiPath made up 0.26% of Bayesian Capital Management's portfolio in Q2 2026, its #112 holding.
Bayesian Capital Management first reported a position in UiPath in Q4 2021 and has held it in 10 quarters since.
Bayesian Capital Management's UiPath position peaked at $3.36M in Q4 2023.
529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.